Veracyte (VCYT) Capital Expenditures Growth (5y) (2017 - 2026)
Veracyte (VCYT) Capital Expenditures Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.36% |
| Mar 31, 2026 | -35.65% |
| Dec 31, 2025 | -74.00% |
| Sep 30, 2025 | -9.48% |
| Jun 30, 2025 | 1.38% |
| Mar 31, 2025 | 74.32% |
| Dec 31, 2024 | -135.56% |
| Sep 30, 2024 | 143.02% |
| Jun 30, 2024 | -59.89% |
| Mar 31, 2024 | 126.55% |
| Dec 31, 2023 | 47.56% |
| Sep 30, 2023 | -35.76% |
| Jun 30, 2023 | -44.79% |
| Mar 31, 2023 | 63.26% |
| Dec 31, 2022 | 32.91% |
| Sep 30, 2022 | -16.28% |
| Jun 30, 2022 | -23.32% |
| Mar 31, 2022 | 119.42% |
| Dec 31, 2021 | -1.82% |
| Sep 30, 2021 | 3.75% |